The release of myeloperoxidase (MPO) by activated neutrophils in the setting of inflammation has been associated with atherosclerotic diseases, namely coronary artery disease and its most grievous manifestation, acute coronary syndrome [60,61]. This evidence concerns the gene MPO and coronary artery disorder.